R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
FDA draft guidance backs alternatives to animal testing in early drug development, outlining validation for new approach ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the ...
The U.S. Food and Drug Administration has issued a draft guidance intended to help drug developers validate new approach methodologies to be used instead of animal testing ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results